← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lohocla Research Corporation
Aurora, CO
$31,525,448
Total funding
9
Grants
Funding over time
peak $5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,525,448 · 9
By mechanism
UH3$9,323,255 · 1
R44$8,094,338 · 3
U44$7,741,542 · 1
UG3$5,652,899 · 1
R43$713,414 · 3
Investigators at Lohocla Research Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A novel therapeutic to ameliorate chronic pain and reduce opiate use$3,973,837
UH3 · FY2021 · DA
A novel therapeutic to ameliorate chronic pain and reduce opiate use$3,283,785
UH3 · FY2022 · DA
A novel therapeutic to ameliorate chronic pain and reduce opiate use$3,270,473
UG3 · FY2020 · DA
A novel therapeutic to ameliorate chronic pain and reduce opiate use$2,382,426
UG3 · FY2019 · DA
A novel therapeutic to ameliorate chronic pain and reduce opiate use$1,925,647
UH3 · FY2023 · DA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$1,710,532
R44 · FY2022 · AA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$1,710,386
R44 · FY2024 · AA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$1,707,595
R44 · FY2025 · AA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$1,500,000
U44 · FY2019 · AA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$1,500,000
U44 · FY2018 · AA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$1,500,000
U44 · FY2017 · AA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$1,000,000
U44 · FY2015 · AA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$985,777
U44 · FY2016 · AA
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder$918,712
U44 · FY2019 · AA
Medications for the Treatment of Alcohol Abuse and Dependence and Relapse$549,928
R44 · FY2008 · AA
Proteomic Markers of Alcohol Abuse (Phase 1)$475,542
R44 · FY2006 · AA
Proteomic Markers of Alcohol Abuse (Phase 1)$474,865
R44 · FY2007 · AA
Medications for the Treatment of Alcohol Abuse and Dependence and Relapse$448,331
R44 · FY2007 · AA
Proteomic Markers of Alcohol Abuse (Phase 1)$399,059
R44 · FY2005 · AA
Monoclonal antibody mediated biomarker discovery for alcohol-induced liver damage$240,065
R43 · FY2008 · AA